Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

22.26

-0.88 (-3.80%)

At close: Aug 12, 2026, 4:00 PM EDT

22.50

+0.24 (1.08%)

After-hours: Aug 12, 2026, 4:10 PM EDT

Caris Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	105.14	-68.09	-281.89	-341.42	-320.83
Depreciation & Amortization	20.76	22.62	48.91	49	48.25
Stock-Based Compensation	65.11	70.01	18.64	15.24	22.9
Other Adjustments	13.01	91.75	-1.8	8.2	-13.78
Change in Receivables	-71.58	-29.79	-33.82	-15.08	-11.91
Changes in Inventories	-79.77	-20.75	5.46	-4.44	-11.1
Changes in Accounts Payable	52.59	11.04	-0.23	7.17	8.91
Changes in Accrued Expenses	40.26	11.48	0.8	1.26	-6.6
Changes in Other Operating Activities	-4.6	-5.1	-1.29	3.96	-1.56
Operating Cash Flow	168.56	83.16	-245.2	-276.1	-285.71
Operating Cash Flow Growth	-	-	-	-	-
Capital Expenditures	-44.6	-16.26	-8.44	-22.32	-42.26
Purchases of Investments	-	-	-	-63.4	-378.38
Proceeds from Sale of Investments	-	-	61.38	300.49	137.65
Investing Cash Flow	-44.6	-16.26	52.93	214.77	-282.99
Long-Term Debt Issued	-	27.87	199.98	191.31	-
Long-Term Debt Repaid	-	-	-	-180	-
Net Long-Term Debt Issued (Repaid)	-	27.87	199.98	11.31	-
Issuance of Common Stock	6.67	536.1	1.53	1.87	11.41
Repurchase of Common Stock	-43.67	-18.66	-	-	-
Net Common Stock Issued (Repurchased)	-36.99	517.43	1.53	1.87	11.41
Issuance of Preferred Stock	-	121.24	-	-	-
Net Preferred Stock Issued (Repurchased)	-	121.24	-	-	-
Other Financing Activities	-5.81	-1.55	-1.22	-3.04	-0.96
Financing Cash Flow	-53.78	664.99	200.29	10.13	10.45
Foreign Exchange Rate Adjustments	-0	0.13	-0	0.06	0
Net Cash Flow	-29.94	732.01	8.02	-51.13	-558.25
Free Cash Flow	123.96	66.9	-253.64	-298.42	-327.96
Free Cash Flow Growth	-	-	-	-	-
FCF Margin	12.53%	8.24%	-61.52%	-97.48%	-126.88%
Free Cash Flow Per Share	0.43	0.40	-7.15	-8.54	-9.83
Levered Free Cash Flow	-17.65	-37.21	-133.06	-416.58	-325.18
Unlevered Free Cash Flow	137.75	48.13	-211.9	-284.92	-320.11

SEC Filings: 10-K · 10-Q